Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
Boehringer Ingelheim
AstraZeneca
McKinsey
Moodys
Medtronic

Last Updated: November 12, 2019

DrugPatentWatch Database Preview

Drug Price Trends for NIGHT TIME COLD-FLU LIQUID

See Plans and Pricing

« Back to Dashboard

Drug Price Trends for NIGHT TIME COLD-FLU LIQUID

Average Pharmacy Cost for NIGHT TIME COLD-FLU LIQUID

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
NIGHT TIME COLD-FLU LIQUID 46122-0404-40 0.00883 ML 2019-10-23
NIGHT TIME COLD-FLU LIQUID 46122-0008-40 0.00883 ML 2019-10-23
NIGHT TIME COLD-FLU LIQUID 46122-0136-40 0.00883 ML 2019-10-23
NIGHT TIME COLD-FLU LIQUID 46122-0198-34 0.01304 ML 2019-10-23
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
Colorcon
AstraZeneca
Medtronic
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.